Analysis of DNA methylation patterns associated with the gastric cancer genome

Oncology Letters

Volumn 7, Issue 4, 2014, Pages 1021-1026

  Cheng, Yi ^a,b   Yan, Zhi ^b   Liu, Yin ^a   Liang, Chengbai ^a   Xia, Hong ^a   Feng, Junming ^b   Zheng, Guorong ^b   Luo, Hesheng ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN GENERAL HOSPITAL OF GUANGZHOU COMMAND   (China)

Author keywords

Gastric cancer, DNA methylation, genome wide, methylation microarray

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ADULT; APOPTOSIS; ARTICLE; BIOINFORMATICS; CELL CYCLE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; DNA EXTRACTION; DNA METHYLATION; DNA MICROARRAY; FEMALE; GENE CONTROL; GENE EXPRESSION; GENOME; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; PYROSEQUENCING; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; STOMACH CANCER; WNT SIGNALING PATHWAY;

EID: 84896700012     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.1838     Document Type: Article

References (13)

1. Leung WK, Wu MS, Kakugawa Y, et al; Asia Pacific Working Group on Gastric Cancer: Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol 9: 279-287, 2008.
2. Brenner H, Rothenbacher D and Arndt V: Epidemiology of stomach cancer. Methods Mol Biol 472: 467-477, 2009.
3. Sapari NS, Loh M, Vaithilingam A and Soong R: Clinical potential of DNA methylation in gastric cancer: a meta-analysis. PLoS One 7: e36275, 2012.
4. Laird PW: Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet 11: 191-203, 2010.
5. Ku CS, Naidoo N, Wu M and Soong R: Studying the epigenome using next generation sequencing. J Med Genet 48: 721-730, 2011.
6. Shenker N and Flanagan JM: Intragenic DNA methylation: implication of this epigenetic mechanism for cancer research. Br J Cancer 106: 248-253, 2012.
7. Lister R, Pelizzola M, Dowen RH, et al: Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462: 315-322, 2009.
8. Sandoval J, Heyn HA, Moran S, et al: Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome. Epigenomics 6: 692-702, 2011.
9. Dedeurwaerder S, Defrance M, Calonne E, et al: Evaluation of the Infinium Methylation 450K technology. Epigenetics 3: 771-784, 2011.
10. Rakyan VK, Down TA, Balding DJ and Beck S: Epigenome-wide association studies for common human diseases. Nat Rev Genet 12: 529-541, 2011.
11. Maunakea AK, Nagarajan RP, Bilenky M, et al: Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466: 253-257, 2010.
12. Ball MP, Li JB, Gao Y, et al: Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol 27: 361-368, 2009.
13. Jjingo D, Conley AB, Yi S, et al: On the presence and role of human gene-body DNA methylation. Oncotarget 3: 462-474, 2012.